Beyond the pap: Assessing patients' priorities for the annual examination

Journal of Women's Health

Volumn 13, Issue 7, 2004, Pages 791-798

  Becker, Heidi I ^a   Longacre, Meghan R ^b   Harper, Diane M ^b,c  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c NORRIS COTTON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER SCREENING; CHI SQUARE TEST; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEMOGRAPHY; DOCTOR PATIENT RELATION; EDUCATION; FEMALE; HEALTH CARE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL EXAMINATION; MEDICAL TECHNOLOGY; PAPANICOLAOU TEST; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REGRESSION ANALYSIS; UNITED STATES; UTERINE CERVIX CANCER;

ADULT; AGED; ATTITUDE TO HEALTH; CHI-SQUARE DISTRIBUTION; FEMALE; FOCUS GROUPS; HUMANS; MASS SCREENING; MIDDLE AGED; NEW ENGLAND; PHYSICAL EXAMINATION; QUESTIONNAIRES; RISK FACTORS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; WOMEN'S HEALTH;

EID: 5644263967     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2004.13.791     Document Type: Article

References (25)

1. Fink DJ. Change in American Cancer Society checkup guidelines for detection of cervical cancer. CA Cancer J Clin 1998;38:127.
2. American Cancer Society. Cancer facts and figures, 2002. Atlanta, GA: American Cancer Society, Inc., 2002. www.cancer.org. Accessed August 11, 2003.
3. Ries LA, Kosary CL, Hankey BF, Miller BA, Edwards BK, eds. SEER cancer statistics review, 1973-1995. Bethesda, MD: National Cancer Institute, 1998.
4. Miller MG, Sung HY, Sawaya GF, Kearney KA, Kinney W, Hiatt RA. Screening interval and risk of invasive squamous cell cervical cancer. Obstet Gynecol 2002;101:29.
5. Myers ER, McCrory DC, Nanda K, Bastian L, Matchar DB. Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am J Epidemiol 2002;151:1158.
6. Oboler SK, Prochazka AV, Gonzales R, Xu S, Anderson RJ. Public expectations and attitudes for annual physical examinations and testing. Ann Intern Med 2002;136:652.
7. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: Terminology for reporting results of cervical cytology. JAMA 2002;287:2114.
8. Saslow D, Runowicz CD, Solomon D, et al. American Cancer Society Guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002;52:342.
9. American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin. Cervical cytology screening. Clinical management guidelines for obstetrician-gynecologists, Number 45, August 2003.
10. Solomon D, Schiffman M, Tarone R, ALTS Study Group. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst. 2001;93:293.
11. Dalstein V, Riethmuller D, Pretet JL, et al. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: A longitudinal French cohort study. Int J Cancer 2003;106:396.
12. Ratnam S, Franco EL, Ferenczy A. Human papillomavirus testing for primary screening of cervical cancer precursors. Cancer Epidemiol Biol Prev 2000; 9:945.
13. Herrero R, Hildesheim A, Bratti C, et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 2000;92:464.
14. Schiffman MH, Burk RD. Human papillomaviruses. In: Evans AS, Kaslow RA, eds. Viral infections of humans: Epidemiology and control, 4th ed. New York: Plenum Medical Book Company, 1997:983.
15. 2003 Clinical laboratory fee schedule and laboratory services subject to reasonable charge payment method for liquid cytology reimbursement. www.health.state. mn.us/divs/hpcd/ccs/mbcccp /rates.htm Accessed December 26, 2003.
16. CPT Codes and Center for Medicare and Medicaid services Reimbursement for Digene HC2 HPV test. www.dphhs.state.mt.us/hpsd/medicaid/pdf/prov32.pdf and www.in.gov/isdh/programs/bccp/pdf/cptcodes2003.pdf Accessed December 26, 2003.
17. Harper DM, Walker JL, Johnson GA, et al. The hidden effect of colposcopy during cervical cancer screening [Abstract] 20th International HPV Conference, Paris, France, October 2002.
18. U.S. census by education level. www.Census.gov Accessed December 26, 2003.
19. Kim JJ, Wright TC, Goldie SJ. Cost effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA 2002;287:2382.
20. U.S. Preventive Services Task Force (USPSTF). Guide to clinical preventive services, 3rd ed, 2000-2003. www.ahrq.gov/clinic/cps3dix.htm Accessed August 12, 2003.
21. Wright TC Jr, Cox JT, Massad LS, Carlson J, Twiggs LB, Wilkinson EJ, for the 2001 American Society for Colposcopy and Cervical Pathology Consensus Conference. 2001. Consensus guidelines for the management of women with cervical intraepithelial neoplasia. Am J Obstet Gynecol 2003;189:295.
22. Sawaya GF, McConnell KJ, Kulasingam LS, et al. Risk of cervical cancer associated with extending the interval between cervical cancer screenings. N Engl J Med 2003;349:1501.
23. Harper DM, Noll WW, Belloni DR, Cole BF. Randomized clinical trial of PCR determined HPV detection methods: Self-sampling vs. clinician directed. Biological concordance and women's preferences. Am J Obstet Gynecol 2002;186:365.
24. Laine C. The annual physical examination: Needless ritual or necessary routine? Ann Intern Med 2002;136:701.
25. Han PK. Historical changes in the objectives of the periodic health examination. Ann Intern Med 1997;127:910.